Anti-Canine NGF Therapeutic Antibody (Ranevetmab)

Recombinant monoclonal antibody to NGF. Ranevetmab is a caninized monoclonal antibody that can be potentially used in the treatment of Osteoarthritis (OA).
Supplier Creative Biolabs
Product # TAB-031ML
Pricing Inquiry
Host Canine
Target NGF
Species Reactivity Canine
Type IgG1, κ
Applications Used for immunoassay techniques such as: Enzyme-Linked Immunosorbent Assay; Immunohistochemistry; Immunofluorescence; Immunoprecipitation; Flow Cytometry; Inhibition
Storage Store at -20°C for long-term storage. Avoid freeze/thaw cycles.
Feedback